Stock Events

Stock Events

CRISPR Therapeutics (C2RS34.SA) Q3 2024 Earnings

5AugConfirmed

Q4 2023

Q2 2024

Q3 2024

-8.52

-3.87

0.78

5.43

Details

Expected EPS

-8.1666757326

Actual EPS

-8.524439

Surprise EPS

-0.36

Surprise Percent

+4.38%

Description

CRISPR Therapeutics (C2RS34.SA) has reported earnings of -8.524439 per share for Q3 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.